Allscripts Healthcare Solutions, Inc. – Nasdaq: MDRX
Allscripts Healthcare Solutions, Inc., traded on the Nasdaq under ticker symbol MDRX, announced preliminary financial results for the fourth quarter ended Dec. 31, 2016. The company anticipates consolidated bookings for the 4th quarter of 2016 to exceed $400 million, a fourth-quarter record. This result implies annual bookings growth of over 17 percent. Shares of MDRX hav responded by increasing almost 10% in early trading.
Paul M. Black, Allscripts’ Chief Executive Officer stated in a press release “Our investments in our solutions continue to increase our competitiveness, reflected in signed agreements which added the largest number of new Sunrise facilities in our history. Our initial outlook for 2017 illustrates confidence this growth momentum will continue this year across Allscripts comprehensive offerings to payers and providers globally.”
Chicago, IL-based Allscripts Healthcare Solutions Inc. is a leader in healthcare information technology solutions that advance clinical, financial, and operational results. Twenty-one firms follow Allscripts Healthcare and twelve rate MDRX as a “Hold”, one rates it as a “Buy” and eight rate MDRX as a “Strong Buy”.
I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 96 hours. All information, or data, is provided with no guarantees of accuracy.